Sugi Predict

Sugi Predict / Compounds / SCHEMBL14970367

SCHEMBL14970367

SCHEMBL14970367

CC(=O)NC1CCC(F)(F)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.47
▸ EPHX2 P34913 2/20 0.47
▸ ATM Q13315 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ IDO1 P14902 1/20 0.36
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ KDM1A O60341 4/20 0.34
▸ BCHE P06276 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33
▸ PSENEN Q9NZ42 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12437203 0.88 EPHX2 (0.59) ALOX15EPHX2ATMALDH1A1KDM4E
SCHEMBL14904407 0.83 ATM (0.42) ALOX15EPHX2ATMALDH1A1KDM4E
SCHEMBL23573248 0.82 EPHX2 (0.41) ALOX15EPHX2IDO1KDM1ACHRM2
SCHEMBL28473546 0.82 EPHX2 (0.41) ALOX15EPHX2IDO1KDM1ACHRM2
SCHEMBL1705702 0.82 EPHX2 (0.41) ALOX15EPHX2IDO1KDM1ACHRM2
Hydrochloric Acid SCHEMBL30777466 0.81 ATM (0.41) ALOX15EPHX2ATMALDH1A1KDM4E
SCHEMBL12886524 0.80 EPHX2 (0.40) ALOX15EPHX2ALDH1A1IDO1KDM1A
SCHEMBL15492438 0.79 EPHX2 (0.41) ALOX15EPHX2IDO1MTNR1AMTNR1B
SCHEMBL15490053 0.77 EPHX2 (0.39) EPHX2IDO1KDM1A
SCHEMBL13195586 0.76 EPHX2 (0.37) EPHX2ALDH1A1IDO1KDM1ACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4346815-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Schrödinger, Inc. (US) 2024-04-10 — — EP disclosed
WO-2022251497-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE SCHRÖDINGER, INC. (US) 2022-12-01 — — WO disclosed
EP-2780337-B1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME (US) 2017-12-20 — — EP disclosed
US-9018224-B2 Substituted cyclopropyl compounds useful as GPR119 agonists MERCK SHARP & DOHME CORP. (US) 2015-04-28 — — US disclosed
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME LLC 2014-11-06 — — US disclosed
WO-2013074388-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME CORP. (US) 2013-05-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS GPR119, GPR27, GCGR ALOX15 1181/4885EPHX2 1476/4885ATM 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.